EUVIMEDEUVIMED entdecken
Crossref

Approach To Diagnosis And Treatment Of Familial Hyperlipidemia

Kübra ÇERÇİ, İmge Bortay TEKİN, Seyit UYAR

DAHUDER Medical Journal · 2023

DOI: 10.56016/dahudermj.1195167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DAHUDER Medical Journal, 2023. Verfasst von Kübra ÇERÇİ und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hyperlipidemia (FH) is an autosomal dominant inherited disease characterized by genetic disorders with severe high blood cholesterol levels. There are two forms of the disease which are homozygous and heterozygous FH. FH cases are generally caused by hereditorial mutations in the LDL receptor (LDL-R) gene and less commonly in genes encoding apolipoprotein B (Apo B) and pro-protein convertase subtilisin/kexin 9 (PCSK9) proteins. The risk of early-onset coronary artery disease (CAD) in FH patients is 20 times higher than the normal population. Early diagnosis and treatment of FH will greatly reduce the morbidity and mortality associated with CAD.

Zitieren

APA

ÇERÇİ, K., TEKİN, İ. B., & UYAR, S. (2023). Approach To Diagnosis And Treatment Of Familial Hyperlipidemia. DAHUDER Medical Journal. https://doi.org/10.56016/dahudermj.1195167

Vancouver

ÇERÇİ K, TEKİN İB, UYAR S. Approach To Diagnosis And Treatment Of Familial Hyperlipidemia. DAHUDER Medical Journal. 2023. doi:10.56016/dahudermj.1195167

BibTeX
@article{ER2023,
  author = {ÇERÇİ, Kübra and TEKİN, İmge Bortay and UYAR, Seyit},
  title = {Approach To Diagnosis And Treatment Of Familial Hyperlipidemia},
  journal = {DAHUDER Medical Journal},
  year = {2023},
  doi = {10.56016/dahudermj.1195167}
}
Kostenlos starten →